Skip to main content

Activation of Natural Cytotoxic Activity In Vitro with Lymphocytes from Patients with Multiple Sclerosis

  • Chapter
Multiple Sclerosis Research in Europe

Abstract

Natural killer (NK) cells are defined as lymphocytes with the capacity to lyse certain tumor cells and virus-infected cells without prior immunization (Herbermann and Holden, 1978). These cells constitute a heterogeneous subset of the lymphoid cell population. It has been demonstrated that interferon (IFN) plays an important role in the regulation of NK activity (Ortaldo et al., 1983). Recently, it has been demonstrated that interleukin-2 (Il-2) can also enhance NK cell activity (Grimm et al., 1983; Devos et al., 1984). Furthermore Il-2 has an important role in the regulation of IFNγ production (Kawase et al., 1983). This was confirmed with pure recombinant Il-2 by Svedersky et al., 1984 and by ourselves. Although the role of the endogenously produced IFNγ in the augmentation of NK activity by Il-2 has been a controversial issue, there is increasing evidence that the enhancement of NK activity by Il-2 is only partly mediated by IFNγ (Svedersky et al., 1984; Braakman et al., manuscript in preparation). Although the precise mechanisms by which NK activity are regulated remain to be established it is attractive to hypothesize that NK cells play a significant role in the natural resistance against virus infections. Among the immunoregulatory abnormalities in MS patients it has been reported that NK activity is decreased (Benczur et al., 1980; Hauser et al., 1981; Uchida et al., 1982, and Neighbour et al., 1982) and that IFN production is impaired (Neighbour and Bloom, 1979, and Benczur et al., 1980).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Benczur, M., Petrányi, G.Gy., Palffy, Gy., Varga, M., Talas, M., Kotsy, B., Foldes, I. and Holden, S.R., 1980. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenic factor. Clin. Exp. Immunol., 39: 657–662.

    PubMed  CAS  Google Scholar 

  • Devos, R., Plaetinck, G. and Fiers, W., 1984. Induction of cytolytic cells by pure recombinant human interleukin 2. Eur. J. Immunol., 14: 1057–1060.

    Article  PubMed  CAS  Google Scholar 

  • Grimm, E.A., Robb, R.J., Roth, J.A., Neckers, L.M., Lachmann, L.B., Wilson, D.J. and Rosenberg, S.A., 1983. Lymphokine activated killer cell phenomenon. III. Evidence that Il-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells. J. Exp. Med., 158: 1356–1361.

    Article  PubMed  CAS  Google Scholar 

  • Hauser, S.L., Ault, K.A., Levin, M.J., Garovoy, M.R. and Weiner, H.L., 1981. Natural killer cell activity in multiple sclerosis. J. Immunol., 127: 1114–1117.

    PubMed  CAS  Google Scholar 

  • Herbermann, R.B. and Holden, H.T., 1978. Natural cell mediated immunity. Adv. Cancer Res., 27: 305.

    Article  Google Scholar 

  • Kawase, I., Brooks, C.G., Kuribayashi, K., Olabuenaga, S., Newman, W., Gillis, S. and Henney, C.S., 1983. Interleukin 2 induces γ interferon production: participation of macrophages and NK-like cells. J. Immunol., 131: 288–292.

    PubMed  CAS  Google Scholar 

  • Merrill, J.E., Jondal, M., Seeley, J., Ullberg, M. and Sidén, A., 1982. Decreased NK killing in patients with multiple sclerosis: An analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity of the disease. Clin. Exp. Immunol., 47: 419–430.

    PubMed  CAS  Google Scholar 

  • Merrill, J.E., Myers, L.W. and Ellison, W., 1983a. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 2. Effect of exogenous PGE1 on spontaneous and interferon induced natural killer. J. Neuroimmunol., 4: 239–251.

    Article  PubMed  CAS  Google Scholar 

  • Merrill, J.E., Gerner, R.H., Myers, L.W. and Ellison, G.W., 1983b. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferon. J. Neuroimmunol., 4: 223–237.

    Article  CAS  Google Scholar 

  • Merrill, J.E., Mohlstrom, C., Uittenbogaart, C., Kermaniarab, V., Ellison, G. W. and Myers, L.W., 1984. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis. J. Immunol., 133: 1931–1937.

    PubMed  CAS  Google Scholar 

  • Neighbour, P.A. and Bloom, B.R., 1979. Absence of virus induced lymphocyte suppression and interferon production in multiple sclerosis. Proc. Natl. Acad. Sci. USA, 76: 476–480.

    Article  PubMed  CAS  Google Scholar 

  • Neighbour, P.A., Graynel, A.I. and Miller, A.E., 1982. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Clin. Exp. Immunol., 49: 11–21.

    PubMed  CAS  Google Scholar 

  • Ortaldo, J.R., Mantovani, A., Hobbs, D., Rubinstein, M., Pestka, S. and Herbermann, R.B., 1983. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int. J. Cancer, 31: 285–289.

    Article  PubMed  CAS  Google Scholar 

  • Rager-Zisman, B. and Bloom, B.R., 1980. Natural killer cells in resistance to virus-infected cells. Springer Sem. Immunopathol., 4: 397–414.

    Article  Google Scholar 

  • Santoli, D., Trinchieri, G., Moretta, L., Zmijewski, C.M. and Koprowski, H., 1978. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell. Clin. Exp. Immunol., 33: 309–318.

    PubMed  CAS  Google Scholar 

  • Santoli, D., Hall, W., Kastrukoff, L., Lisak, R.P., Perussia, B., Trinchieri, G. and Koprowski, H., 1981. Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J. Immunol., 126: 1274–1278.

    PubMed  CAS  Google Scholar 

  • Svedersky, L.P., Shepard, H.M., Spemcer, S.A., Shalby, M.R. and Palladine, M.A., 1984. Augmentation of human natural cell mediated cytotoxicity by recombinant human interleukin 2. J. Immunol., 133: 714–718.

    PubMed  CAS  Google Scholar 

  • Uchida, A., Maida, E.M., Lenzhofer, R. and Micksche, M., 1982. Natural killer cell activity in patients with multiple sclerosis: Interferon and plasmaphoresis. Immunobiol., 160: 392–402.

    CAS  Google Scholar 

  • Zöller, M. and Wigzell, H., 1982. Normally occurring inhibitory cells for natural killer cell activity. II. Characterization of the inhibitory cell. Cell. Immunol., 74: 27–39.

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 ECSC, EEC, EAEC, Brussels and Luxembourg

About this chapter

Cite this chapter

Braakman, E., Van Tunen, A., Lucas, C.J. (1986). Activation of Natural Cytotoxic Activity In Vitro with Lymphocytes from Patients with Multiple Sclerosis. In: Hommes, O.R. (eds) Multiple Sclerosis Research in Europe. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4143-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4143-4_25

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8338-6

  • Online ISBN: 978-94-009-4143-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics